IL6 and COVID-19: Recent reports have concluded that the imbalance between hyperinflammation and immune paralysis is a hallmark of sepsis [75] and that the levels of inflammatory biomarkers such as interleukin 6 in patients with COVID-19 are associated with mortality [76].